US Stocks
/
Immunome, Inc. Share Price
Immunome, Inc. Share Price

Immunome, Inc. Share Price

NASDAQ: IMNM | Small Cap
$19.56
+$0.23 (1.22%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunome, Inc. Stock Performance

Open
$19.20
Prev. Close
$19.32
Circuit Range
N/A
Day Range
$18.95 - $19.69
Year Range
$13.52 - $30.05
Volume
75,587
Average Traded
$19.54

Immunome, Inc. Share Price Today

As of 10 October 2026, Immunome, Inc.'s share price is $19.56. The stock opened at $19.20, compared to its previous close of $19.32. During today's trading session, Immunome, Inc.'s share price traded between $18.95 and $19.69, with an average price of $19.32. Over the past 52 weeks, the stock has recorded a high of $30.05 and a low of $13.52. In terms of performance, Immunome, Inc.'s share price has declined by 14.73% over the last six months and is up 21.72% on a year-on-year basis.

Immunome, Inc. Share Price Chart

$18.95$19.69
L
Show Current Price
H

Immunome, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.71B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.16
Revenue (TTM)
$6.94B
Return On Equity (TTM)
-48.43%
Profit Margin
-3060.37%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-27.27%

Immunome, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$57.46-$69.90-$53.84-$73.13
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21.65%22.98%-35.83%

Immunome, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$14.02$9.04$6.94
Net Profit-$37.52-$106.81-$292.96-$212.39
Net Profit MarginN/A-761.84%-3240.71%-3060.37%
Income ChangeN/A-184.67%-174.28%27.50%

About Immunome, Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Immunome, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$21.40
$19.55
-9.30%
Sep 2026
$27.23
$21.56
-25.36%
Aug 2026
$22.84
$28.89
+26.86%
Jul 2026
$20.65
$22.77
+7.36%
Jun 2026
$20.61
$21.21
-2.71%
May 2026
$23.09
$21.80
-4.97%
Apr 2026
$22.22
$22.94
+4.75%
Mar 2026
$21.91
$21.90
+0.18%
Feb 2026
$24.55
$21.86
-11.03%
Jan 2026
$21.48
$24.57
+14.28%
Dec 2025
$18.22
$21.50
+16.72%
Nov 2025
$16.14
$18.42
+14.62%

IMNM Share Price FAQs

What is Immunome, Inc. share price today?

chevron-up
Immunome, Inc. share price today is $19.56 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immunome, Inc. stock?

chevron-up
The 52 week high of Immunome, Inc. stock is $30.05, while the 52 week low is $13.52 as of 10 Oct '26.

What is IMNM's market capitalisation today?

chevron-up
IMNM market capitalisation is $1.71B as of October 10, 2026, at 6:23 pm IST.

What is IMNM's net income for the last quarter?

chevron-up
IMNM's net income for the last quarter is -73.13B USD.

What is the 5 year returns of IMNM?

chevron-up
The 5 year returns of IMNM is -16.55% as on 10 Oct '26.

What is the high & low stock price of IMNM today?

chevron-up
IMNM stock price hit a high of $19.69 and low of $18.95 as of 10 Oct '26.

Can I buy IMNM shares in India?

chevron-up
Yes. You can buy IMNM in India by opening an international trading account.